Trial Outcomes & Findings for Contract-Relax (CR) Technique in the Management of Diaphragmatic Paresis After Cardiac Surgery (NCT NCT05068219)

NCT ID: NCT05068219

Last Updated: 2026-06-08

Results Overview

Diaphragmatic excursion ratio during maximum inspiration, assessed separately for the left and right hemidiaphragms by ultrasound in TM mode. Measurements were obtained at Day 3 before the first rehabilitation session of the day (M1max, diaphragmatic displacement in mm) and at Day 5 before the first rehabilitation session of the day (M2max, diaphragmatic displacement in mm). The reported values correspond to the ratio of diaphragmatic excursion at Day 5 relative to Day 3 (M2max/M1max).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

27 participants

Primary outcome timeframe

Days 3 and 5

Results posted on

2026-06-08

Participant Flow

Participant milestones

Participant milestones
Measure
Usual Technique
Standard rehabilitation
CR Technique
Standard rehabilitation + 3 CR
Overall Study
STARTED
14
13
Overall Study
COMPLETED
14
13
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Total
n=27 Participants
Total of all reporting groups
Age, Continuous
71 years
n=14 Participants
66 years
n=13 Participants
70 years
n=27 Participants
Sex: Female, Male
Female
2 Participants
n=14 Participants
3 Participants
n=13 Participants
5 Participants
n=27 Participants
Sex: Female, Male
Male
12 Participants
n=14 Participants
10 Participants
n=13 Participants
22 Participants
n=27 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Laterality of diaphragmatic paresis
Right-sided
4 Participants
n=14 Participants
6 Participants
n=13 Participants
10 Participants
n=27 Participants
Laterality of diaphragmatic paresis
Left-sided
3 Participants
n=14 Participants
1 Participants
n=13 Participants
4 Participants
n=27 Participants
Laterality of diaphragmatic paresis
Bilateral
7 Participants
n=14 Participants
6 Participants
n=13 Participants
13 Participants
n=27 Participants

PRIMARY outcome

Timeframe: Days 3 and 5

Population: The analysis was performed separately for the left and right sides, and not all patients had bilateral diaphragmatic paresis.

Diaphragmatic excursion ratio during maximum inspiration, assessed separately for the left and right hemidiaphragms by ultrasound in TM mode. Measurements were obtained at Day 3 before the first rehabilitation session of the day (M1max, diaphragmatic displacement in mm) and at Day 5 before the first rehabilitation session of the day (M2max, diaphragmatic displacement in mm). The reported values correspond to the ratio of diaphragmatic excursion at Day 5 relative to Day 3 (M2max/M1max).

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Diaphragmatic Excursion in Maximum Inspiration
Right-sided diaphragmatic excursion ratio
1.64 ratio
Interval 1.42 to 2.01
1.88 ratio
Interval 1.82 to 2.75
Diaphragmatic Excursion in Maximum Inspiration
Left-sided diaphragmatic excursion ratio
1.75 ratio
Interval 1.36 to 2.11
1.46 ratio
Interval 0.95 to 2.2

SECONDARY outcome

Timeframe: Days 3 and 5

Population: The analysis was performed separately for the left and right sides, and not all patients had bilateral diaphragmatic paresis.

Diaphragmatic excursion ratio during normal inspiration, assessed separately for the left and right hemidiaphragms by ultrasound in TM mode. Measurements were obtained at Day 3 before the first rehabilitation session of the day (M1rest, diaphragmatic displacement in mm) and at Day 5 before the first rehabilitation session of the day (M2rest, diaphragmatic displacement in mm). The reported values correspond to the ratio of diaphragmatic excursion at Day 5 relative to Day 3 (M2rest/M1rest).

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Diaphragmatic Excursion in Normal Inspiration
Right-sided diaphragmatic excursion ratio
1.22 ratio
Interval 1.0 to 1.69
1.42 ratio
Interval 1.19 to 1.86
Diaphragmatic Excursion in Normal Inspiration
Left-sided diaphragmatic excursion ratio
1.36 ratio
Interval 1.07 to 1.91
1.11 ratio
Interval 0.83 to 1.63

SECONDARY outcome

Timeframe: Days 3, 4 and 5

SpO2 (%) before and after each physiotherapy session on D3 and D4 and before the first rehabilitation session of the day on D5.

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Oxygen Saturation
SpO2 Day3 - Before physiotherapy session 4
95.5 Percentage of oxygenated hemoglobin
Interval 94.0 to 97.0
96.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 96.0
Oxygen Saturation
SpO2 Day3 - After physiotherapy session 4
96.0 Percentage of oxygenated hemoglobin
Interval 94.7 to 97.2
97.0 Percentage of oxygenated hemoglobin
Interval 96.0 to 98.0
Oxygen Saturation
SpO2 Day4 - Before physiotherapy session 1
96.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 98.0
94.0 Percentage of oxygenated hemoglobin
Interval 92.0 to 95.0
Oxygen Saturation
SpO2 Day4 - After physiotherapy session 1
95.0 Percentage of oxygenated hemoglobin
Interval 95.0 to 96.0
95.0 Percentage of oxygenated hemoglobin
Interval 95.0 to 96.0
Oxygen Saturation
SpO2 Day4 - Before physiotherapy session 2
95.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 97.0
93.0 Percentage of oxygenated hemoglobin
Interval 93.0 to 95.5
Oxygen Saturation
SpO2 Day4 - After physiotherapy session 2
96.0 Percentage of oxygenated hemoglobin
Interval 95.0 to 96.0
96.0 Percentage of oxygenated hemoglobin
Interval 95.2 to 97.7
Oxygen Saturation
SpO2 Day4 - Before physiotherapy session 3
95.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 96.0
94.5 Percentage of oxygenated hemoglobin
Interval 93.2 to 96.0
Oxygen Saturation
SpO2 Day4 - After physiotherapy session 3
96.0 Percentage of oxygenated hemoglobin
Interval 95.0 to 98.0
97.0 Percentage of oxygenated hemoglobin
Interval 95.2 to 98.0
Oxygen Saturation
SpO2 Day4 - Before physiotherapy session 4
96.0 Percentage of oxygenated hemoglobin
Interval 94.7 to 96.2
95.5 Percentage of oxygenated hemoglobin
Interval 94.0 to 96.0
Oxygen Saturation
SpO2 Day4 - After physiotherapy session 4
96.0 Percentage of oxygenated hemoglobin
Interval 95.0 to 98.0
96.5 Percentage of oxygenated hemoglobin
Interval 95.0 to 97.7
Oxygen Saturation
SpO2 Day5
95.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 97.0
96.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 97.0
Oxygen Saturation
SpO2 Day3 - Before physiotherapy session 1
96.0 Percentage of oxygenated hemoglobin
Interval 93.0 to 97.0
96.0 Percentage of oxygenated hemoglobin
Interval 93.5 to 96.5
Oxygen Saturation
SpO2 Day3 - After physiotherapy session 1
95.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 96.0
95.0 Percentage of oxygenated hemoglobin
Interval 93.5 to 98.0
Oxygen Saturation
SpO2 Day3 - Before physiotherapy session 2
95.0 Percentage of oxygenated hemoglobin
Interval 93.7 to 95.5
96.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 97.5
Oxygen Saturation
SpO2 Day3 - After physiotherapy session 2
95.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 96.0
97.0 Percentage of oxygenated hemoglobin
Interval 93.5 to 99.0
Oxygen Saturation
SpO2 Day3 - Before physiotherapy session 3
95.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 98.0
96.0 Percentage of oxygenated hemoglobin
Interval 95.0 to 97.0
Oxygen Saturation
SpO2 Day3 - After physiotherapy session 3
96.0 Percentage of oxygenated hemoglobin
Interval 94.0 to 98.0
97.0 Percentage of oxygenated hemoglobin
Interval 95.7 to 98.2

SECONDARY outcome

Timeframe: from Baseline (Day 0) through Day 30

Population: Patients requiring noninvasive ventilation.

Duration of non-invasive ventilation : NIV, optiflow, CPAP (hours).

Outcome measures

Outcome measures
Measure
Usual Technique
n=5 Participants
Standard rehabilitation
CR Technique
n=7 Participants
Standard rehabilitation + 3 CR
Non-invasive Ventilation
4.0 hours
Interval 3.7 to 11.0
32.9 hours
Interval 23.5 to 36.2

SECONDARY outcome

Timeframe: from Baseline (Day 0) through Day 30

Time of oxygen therapy weaning (days). The reference time t0 will be the time of postoperative extubation.

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Oxygenation
3.68 days
Interval 3.36 to 5.61
4.83 days
Interval 3.26 to 5.53

SECONDARY outcome

Timeframe: from Baseline (Day 0) through Day 30

Occurence of reintubation, lung disease, atelectasis, bronchial fibroscopy, bronchospasm, pleural effusion, pneumothorax.

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Incidence of Respiratory Complications
Reintubation
0 Participants
1 Participants
Incidence of Respiratory Complications
Lung disease
2 Participants
2 Participants
Incidence of Respiratory Complications
Atelectasis
7 Participants
9 Participants
Incidence of Respiratory Complications
Bronchial fibroscopy
0 Participants
0 Participants
Incidence of Respiratory Complications
Bronchospasm
0 Participants
0 Participants
Incidence of Respiratory Complications
Pleural effusion
1 Participants
1 Participants
Incidence of Respiratory Complications
Pneumothorax
0 Participants
0 Participants

SECONDARY outcome

Timeframe: from Baseline (Day 0) through Day 30

Duration of ICU stay (days).

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Intensive Care Unit ICU Length of Stay
4 days
Interval 3.0 to 7.0
4 days
Interval 3.0 to 8.0

SECONDARY outcome

Timeframe: from Baseline (Day 0) through Day 30

Duration of hospitalization (days).

Outcome measures

Outcome measures
Measure
Usual Technique
n=14 Participants
Standard rehabilitation
CR Technique
n=13 Participants
Standard rehabilitation + 3 CR
Hospital Length of Stay
9 days
Interval 8.0 to 11.0
8 days
Interval 8.0 to 14.0

SECONDARY outcome

Timeframe: Days 3 and 4

Self-assessment by the patient of the pain felt with a Numeric Rating Scale (NRS) from 0 (No pain) to 10 (Worst Possible Pain) after each session of respiratory physiotherapy at D3 and D4.

Outcome measures

Outcome measures
Measure
Usual Technique
n=13 Participants
Standard rehabilitation
CR Technique
n=12 Participants
Standard rehabilitation + 3 CR
Pain Score : Numeric Rating Scale (NRS)
NRS Day3 - physiotherapy session 1
4 Score on a scale
Interval 2.0 to 4.0
4 Score on a scale
Interval 3.0 to 5.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day3 - physiotherapy session 2
3 Score on a scale
Interval 2.0 to 4.0
3 Score on a scale
Interval 2.0 to 4.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day3 - physiotherapy session 3
3 Score on a scale
Interval 2.0 to 4.0
3 Score on a scale
Interval 2.0 to 4.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day3 - physiotherapy session 4
2 Score on a scale
Interval 2.0 to 3.0
3 Score on a scale
Interval 2.0 to 4.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day4 - physiotherapy session 1
2 Score on a scale
Interval 1.0 to 3.0
2 Score on a scale
Interval 1.0 to 3.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day4 - physiotherapy session 2
2 Score on a scale
Interval 1.0 to 2.0
2 Score on a scale
Interval 0.0 to 3.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day4 - physiotherapy session 3
2 Score on a scale
Interval 0.0 to 3.0
2 Score on a scale
Interval 0.0 to 3.0
Pain Score : Numeric Rating Scale (NRS)
NRS Day4 - physiotherapy session 4
2 Score on a scale
Interval 1.0 to 3.0
1 Score on a scale
Interval 0.0 to 2.0

Adverse Events

Usual Technique

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

CR Technique

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Maxence BURELLE

CMC Ambroise Paré Hartmann

Phone: 01 46 41 31 26

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place